|

MHB039A for Injection Clinical Trials

3 actively recruiting trials

Pipeline

Phase 2: 1Phase 1/2: 2

Top Sponsors

  • Minghui Pharmaceutical (Hangzhou) Ltd3

Indications

  • Cancer3
  • Advanced Malignant Solid Tumor2
  • Advanced Lung Cancer1
  • Advanced Breast Cancer1
  • Lung Cancer1

Other3 trials

A Study of MHB036C Combined With Anti-tumor Therapies in Patients With Advanced Lung Cancer
Phase 1/2
A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors
Phase 2
A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.